ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • Clin Pharmacol Biopharm,
  • DOI: 10.4172/2167-065X.1000425

Exploring Postmortem Clinical Pharmacology: Insights beyond Death

Sabrina Browne*
Department of Pharmacology, Monash University, Australia
*Corresponding Author : Sabrina Browne, Department of Pharmacology, Monash University, Australia, Email: sanrinabrowne@monash.edu

Received Date: Mar 01, 2024 / Accepted Date: Mar 29, 2024 / Published Date: Mar 29, 2024

Abstract

Postmortem clinical pharmacology represents a vital component of forensic medicine, offering valuable insights into drug-related deaths, toxicological profiles, and pharmacokinetic parameters in deceased individuals. This abstract explores the significance of postmortem clinical pharmacology, its methodologies, applications, and ethical considerations in forensic investigations. By employing sophisticated analytical techniques, forensic pharmacologists contribute to elucidating the cause and manner of death, assessing drug-related risks, and advancing forensic science. Despite challenges and ethical considerations, postmortem pharmacology continues to play a critical role in ensuring justice and public health safety beyond death.

Keywords: Postmortem clinical pharmacology; Forensic medicine; Toxicological profiles; Forensic investigations

Top